Erythropoietin Ameliorate Acute Kidney Injury after Cardiac Valves Surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002266

Enrollment

Unknown

Registered

2012-06-13

Start date

2010-01-04

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury

Interventions

EPO:1wu of EPO was Subcutaneous Injected before and 24

CTL:conventional therapy

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. age 18-70 years old; 2. need cardiac valves surgery under extracorporeal Circulation; 3. sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Basement eGFR<50 ml/min; 2. Low cardiac output or persistant hypotension (systolic pressure <90mmHg, or mean arterial pressure <60mmHg) due to complication in surgery or after surgery.

Design outcomes

Primary

Measure	Time frame
incidence of AKI after cardiac surgery;	—

Countries

China

Contacts

Public ContactHan Guofeng

guofenghan@yahoo.com.cn+86 021 81815127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026